Aqtual
PrivateLast Round
Series B
Jul 10, 2025
Total Funding Raised
$47M
Momentum Score
50 /100
Company Overview
Aqtual is a biotechnology company that offers an innovative analytical platform for cancer drug treatment by capturing molecular signals in circulating DNA to enhance diagnostic accuracy and facilitate personalized patient care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqtual Comps
Public and private peers based on sector, stage, and business model.
Aqtual Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 10, 2025 | ||||
| Series A | Oct 31, 2023 |
Aqtual Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genoa Ventures | Series B, Series A |
| BOLD Capital Partners | Series B |
| Bold Longevity Growth Fund | Series B |
| Manta Ray Ventures | Series B, Series A |
| Yu Galaxy | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2025
$31M round completed.
Aqtual Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aqtual's valuation, stock price, and market status.
